Literature DB >> 23193230

Assessing the effects of pharmacological agents on respiratory dynamics using time-series modeling.

Kin Foon Kevin Wong1, Jen J Gong, Joseph F Cotten, Ken Solt, Emery N Brown.   

Abstract

Developing quantitative descriptions of how stimulant and depressant drugs affect the respiratory system is an important focus in medical research. Respiratory variables-respiratory rate, tidal volume, and end tidal carbon dioxide-have prominent temporal dynamics that make it inappropriate to use standard hypothesis-testing methods that assume independent observations to assess the effects of these pharmacological agents. We present a polynomial signal plus autoregressive noise model for analysis of continuously recorded respiratory variables. We use a cyclic descent algorithm to maximize the conditional log likelihood of the parameters and the corrected Akaike's information criterion to choose simultaneously the orders of the polynomial and the autoregressive models. In an analysis of respiratory rates recorded from anesthetized rats before and after administration of the respiratory stimulant methylphenidate, we use the model to construct within-animal z-tests of the drug effect that take account of the time-varying nature of the mean respiratory rate and the serial dependence in rate measurements. We correct for the effect of model lack-of-fit on our inferences by also computing bootstrap confidence intervals for the average difference in respiratory rate pre- and postmethylphenidate treatment. Our time-series modeling quantifies within each animal the substantial increase in mean respiratory rate and respiratory dynamics following methylphenidate administration. This paradigm can be readily adapted to analyze the dynamics of other respiratory variables before and after pharmacologic treatments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23193230      PMCID: PMC6376979          DOI: 10.1109/TBME.2012.2225834

Source DB:  PubMed          Journal:  IEEE Trans Biomed Eng        ISSN: 0018-9294            Impact factor:   4.538


  20 in total

1.  A signal estimation approach to functional MRI.

Authors:  V Solo; P Purdon; R Weisskoff; E Brown
Journal:  IEEE Trans Med Imaging       Date:  2001-01       Impact factor: 10.048

2.  Locally regularized spatiotemporal modeling and model comparison for functional MRI.

Authors:  P L Purdon; V Solo; R M Weisskoff; E N Brown
Journal:  Neuroimage       Date:  2001-10       Impact factor: 6.556

3.  Influence of chemoreflexes on respiratory variability in healthy subjects.

Authors:  Joost G Van den Aardweg; John M Karemaker
Journal:  Am J Respir Crit Care Med       Date:  2002-04-15       Impact factor: 21.405

Review 4.  A new look at the respiratory stimulant doxapram.

Authors:  C Spencer Yost
Journal:  CNS Drug Rev       Date:  2006 Fall-Winter

5.  D1-dopamine receptor agonists prevent and reverse opiate depression of breathing but not antinociception in the cat.

Authors:  Peter M Lalley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-02-10       Impact factor: 3.619

6.  Ampakine therapy to counter fentanyl-induced respiratory depression.

Authors:  John J Greer; Jun Ren
Journal:  Respir Physiol Neurobiol       Date:  2009-03-04       Impact factor: 1.931

7.  Dopamine1 receptor agonists reverse opioid respiratory network depression, increase CO2 reactivity.

Authors:  Peter M Lalley
Journal:  Respir Physiol Neurobiol       Date:  2004-02-25       Impact factor: 1.931

8.  Ampakine CX717 protects against fentanyl-induced respiratory depression and lethal apnea in rats.

Authors:  Jun Ren; Xiuqing Ding; Gregory D Funk; John J Greer
Journal:  Anesthesiology       Date:  2009-06       Impact factor: 7.892

9.  The effect of remifentanil on respiratory variability, evaluated with dynamic modeling.

Authors:  G D Mitsis; R J M Governo; R Rogers; K T S Pattinson
Journal:  J Appl Physiol (1985)       Date:  2009-02-05

10.  Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care.

Authors:  R M Venn; J Hell; R M Grounds
Journal:  Crit Care       Date:  2000-07-31       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.